APC and malignant colon neoplasm: In 1999, it was already demonstrated that PPARβ/δ was overexpressed in colorectal cancers (CRC) with adenomatous polyposis coli (APC)/β-catenin mutations, leading to the prevention of apoptosis in colon cancer cells.